- Home
- CBU vs CORT Comparison
CBU vs CORT Comparison
Compare CBU & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBU | CORT |
|---|---|---|
| Founded | 1866 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.7B |
| IPO Year | 1994 | 2001 |
Fundamental Metrics
Financial Performance| Metric | CBU | CORT |
|---|---|---|
| Price | $64.82 | $76.55 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $66.67 | ★ $96.50 |
| AVG Volume (30 Days) | 214.6K | ★ 1.0M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.02% | N/A |
| EPS Growth | ★ 15.41 | N/A |
| EPS | ★ 1.08 | N/A |
| Revenue | ★ $818,007,000.00 | $761,407,000.00 |
| Revenue This Year | $13.46 | $26.08 |
| Revenue Next Year | $7.75 | $26.98 |
| P/E Ratio | $59.17 | ★ N/A |
| Revenue Growth | 9.61 | ★ 12.79 |
| 52 Week Low | $51.12 | $28.66 |
| 52 Week High | $67.50 | $91.00 |
Technical Indicators
Market Signals| Indicator | CBU | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 58.89 | 82.45 |
| Support Level | $60.80 | $68.20 |
| Resistance Level | $64.83 | $79.89 |
| Average True Range (ATR) | 1.34 | 2.63 |
| MACD | 0.05 | 0.64 |
| Stochastic Oscillator | 72.41 | 97.85 |
Price Performance
Historical ComparisonAbout CBU Community Bank System Inc.
Community Financial System Inc is a diversified financial services company providing a broad array of banking and other financial services to retail, commercial, institutional, and governmental customers. The Company also offers comprehensive financial planning, trust administration, and wealth management services through its Community Bank Wealth Management operating unit. It has four reportable operating business segments: Banking and Corporate, Employee Benefit Services, Insurance Services, and Wealth Management Services. The group generates the majority of its revenue from the Banking and Corporate segment.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.